CCR News Archives
CCR News Archives
2023
- New CAR T-cell therapy eliminates rhabdomyosarcoma in mice
- CCR Hosts “Frontiers in Basic Immunology” Symposium
- Clinical trial researches radiation therapy for prostate tumors
- Clinical trial researches targeted therapy for biliary tract cancers
- CCR researchers receive an array of HHS awards
- Clinical trial researches focal therapy for prostate cancer
- Clinical trial researches combination drug therapy for kidney cancer
- Clinical trial researches CAR T-cell therapy for B-cell cancers
- Clinical trial researches antibiotic therapy for lung cancer
- New findings highlight shared features of human and canine osteosarcoma
- Clinical trial researching immunotherapy for lung cancer
- Clinical trial researching therapy for recurrent respiratory papillomatosis
- Shining a light on an elusive cancer metabolite
- Seldom-studied immune cells in the liver may be helpful in treating cancer
- Clinical trial researches bone marrow transplants for blood cancers
- CCR Hosts Communications Course for Healthcare Providers in Oncology
- Chromatin modifier linked to immunotherapy resistance in HPV-negative head and neck cancers
- New insights explain how the same protein can serve different functions
- New T-cell therapy shrinks solid tumors in early-phase clinical trial
- Studies of an experimental ovarian cancer therapy identify a biomarker of treatment response
- New analysis reveals potential effective drug combinations for treating lung cancer
- Cells’ decision to divide is reversible
- Drug combination provides a one-two punch attack against colorectal cancer
- Clinical trial researching immunotherapy for tumors with specific genetic deficiencies
- Clinical trial researching therapy for recurrent respiratory papillomatosis
- Clinical trial researching T-cell therapy for epithelial cancers
- Targeting sugar-molecule tags to proteins in the treatment of aggressive lymphomas
- Clinical trial researches therapy for pancreatic acinar cell carcinoma (PACC)
- Clinical trial researching therapy for aggressive blood cancers
- Clinical trial researches therapy for metastatic melanoma or renal cell carcinoma
- Clinical trial researches drug therapy for chronic graft-versus-host disease
- Clinical trial researches drug therapy for CNS tumors
- 2023 Frontiers in Basic Immunology
- With new database, NCATS data is poised to support development of precision cancer therapies
- Andre Nussenzweig elected to the National Academy of Sciences
- Clinical trial researches drug therapy for prostate cancer
- In Memoriam: W. Michael Kuehl, M.D.
- Naomi Taylor and Peter Choyke elected to the Association of American Physicians
- Clinical trial researching stem cell therapy for acute myeloid leukemia
- Andre Nussenzweig and Sandra Wolin elected to American Academy of Arts and Sciences
- Clinical trial researching chemotherapy for bile duct cancer
- How immunotherapy before surgery boosts systemic immunity in head and neck cancer
- Clinical trial researching therapy for blood cancers
- Clinical trial researching CAR T-cell therapy for leukemia and lymphoma
- Elaine S. Jaffe receives FASEB Lifetime Achievement Award
- Clinical trial researching therapy for aggressive gliomas
- NIH study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis
- Clinical trial researching therapy for HIV-associated blood cancers
- Clinical trial researches combination drug therapy for B-cell lymphoma of the central nervous system
- Signals released from dying cancer cells accelerate metastatic tumor growth
- Researchers discover the multiple shapes of RNA, a boon for drug design
- New Milestones publication now available
- A rare look into what makes mesothelioma aggressive, and potentially treatable
- Howard A. Young, Ph.D., Elected as 2022 Fellow of the American Association for the Advancement of Science
- In Memoriam: John J. DiGiovanna
- In Memoriam: James M. Phang, M.D.
- Extrachromosomal DNA promotes aggressiveness of small cell lung cancer
- First clinical trial testing a prevention for breast cancer metastasis to the brain yields encouraging results
- 4th NCI Symposium on Cancer Health Disparities - Registration Deadline March 28, 2023!
- 2023 NCI RNA Biology Symposium - Registration and Abstract Submission Now Open!
- INSPIRED Symposium - Registration Now Open!
- Researchers create a novel cancer drug delivery system inspired by bacterial spores
- In Memoriam: Ji Ming Wang, M.D., Ph.D. (1950 – 2022)
2022
- Researchers uncover stable molecular networks inside liver tumors
- Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?
- When chemotherapy interrupts genetic programs critical for neuronal development and activity, cells accrue DNA damage and die
- Researchers exploit novel vulnerability to deprive solid tumors of nutrients
- Clinical trial researching combination drug therapy for multiple myeloma
- New insights into why smoking causes fatty liver disease
- Steven A. Rosenberg selected as Icon in Surgery by ACS
- NCI RNA Biology Initiative Retreat - October 25, 2022
- Biology & Biophysics of the Nucleus Symposium - October 20-21, 2022
- Clinical trial researching therapy for bile duct cancer
- Celebrating Hispanic Heritage Month: A Conversation with Cecilia Monge, M.D., M.P.H., F.A.C.P.
- Celebrating Hispanic Heritage Month: A Conversation with Kylynda Bauer, Ph.D.
- Clinical trial evaluates drug combination for inoperable neuroendocrine tumors
- Clinical trial researching T-cell therapy for sarcoma
- T-cell imbalance can impact immunotherapy outcomes
- Mapping cells’ mechanical properties for insight into metastasis
- Clinical trial researching therapy for tumors that have spread to the lining of the abdomen
- Clinical trial researches drug therapy for bone marrow neoplasms
- Liver cancer may unexpectedly be influenced by platelets
- Clinical trial researching therapy for prostate cancer
- Clinical trial researching therapy for cancers of the reproductive system
- Study finds that enzyme can disentangle strands of DNA and RNA
- New insights into the origins of an aggressive form of lymphoma
- Bacteria inside lung tumors concentrate within cancer cells
- Immune receptors recognizing mutations in p53 could guide immunotherapies for solid tumors
- CCR postdoctoral researcher awarded Fulbright to study HPV and cervical cancer in Africa
- A protein predicts poor breast cancer survival for women of African descent
- New way to classify meningioma brain tumors suggests potential treatments
- 2022 Cancer Immunology and Immunotherapy Conference: Discovery to Mainstream Oncology
- Clinical trial researches immunotherapy for recurrent thymoma and thymic carcinoma
- Sung-Yun Pai selected for Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program
- Celebrating Asian American, Native Hawaiian, and Pacific Islander Heritage Month: A Conversation with Lilian Yang, M.B.A.
- Celebrating AANHPI Heritage Month: A Conversation with Suresh Ambudkar, Ph.D.
- Clinical trial researching immunotherapy for B-cell lymphoma
- Celebrating AANHPI Heritage Month: A Conversation with Fatima Karzai, M.D.
- Machine learning reveals rules of T cell activation
- Clinical trial researches CAR T-cell therapy for hairy cell leukemia